4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-24-004520
Options or other derivatives
- Chief Executive Officer acquired 9,329,568 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Rawcliffe Adrian Chief Executive Officer | 2024-01-15 | Grant or award · Option to purchase Ordinary Shares | +7,633,296 | 7,633,296 | D | ||
| Rawcliffe Adrian Chief Executive Officer | 2024-01-15 | Grant or award · Option to purchase Ordinary Shares | +1,696,272 | 1,696,272 | D | ||
Loading xslF345X05/tm243270-5_4seq1.xml…